NEW YORK (AP) — NEW YORK (AP) — Oramed Pharmaceuticals Inc. (ORMP) on Thursday reported net income of $13.3 million in its second quarter.

On a per-share basis, the New York-based company said it had profit of 31 cents. Losses, adjusted for non-recurring gains, were 5 cents per share.

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ORMP at https://www.zacks.com/ap/ORMP

For copyright information, check with the distributor of this item, STATS Perform dba Automated Insights.